Lung Cancer Screening

• Autores: Richard M. Hoffman, Rolando Sanchez
• Localización: Medical clinics of North America, ISSN 0025-7125, Vol. 101, Nº. 4, 2017 (Ejemplar dedicado a: Disease Prevention), págs. 769-785
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Lung cancer is the leading cause of cancer death in the United States. More than 80% of these deaths are attributed to tobacco use, and primary prevention can effectively reduce the cancer burden. The National Lung Screening Trial showed that low-dose computed tomography (LDCT) screening could reduce lung cancer mortality in high-risk patients by 20% compared with chest radiography. The US Preventive Services Task Force recommends annual LDCT screening for persons aged 55 to 80 years with a 30-pack-year smoking history, either currently smoking or having quit within 15 years.